Aptinyx Inc reported $5.07M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Biogen BIIB:US $ 637.3M 42.3M
Cara Therapeutics CARA:US $ 5.65M 683K
Daiichi Sankyo 4568:JP 79.12B 24.69B
Eli Lilly And LLY:US $ 1.69B 109.7M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Intra Cellular Therapies ITCI:US $ 69.85M 17.27M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Marinus Pharmaceuticals MRNS:US 6.83M 3.55M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M